Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

New Onset of Suicidal Impulses Following Abrupt Cessation of Valproate.

Ladwig J, Andreae D, Grohmann R, Toto S, Kropp S, Bleich S.

Pharmacopsychiatry. 2017 Nov;50(6):270. doi: 10.1055/s-0043-109240. Epub 2017 May 8. German. No abstract available.

PMID:
28482360
2.

Sleep quality of German soldiers before, during and after deployment in Afghanistan-a prospective study.

Danker-Hopfe H, Sauter C, Kowalski JT, Kropp S, Ströhle A, Wesemann U, Zimmermann PL.

J Sleep Res. 2017 Jun;26(3):353-363. doi: 10.1111/jsr.12522. Epub 2017 Apr 4.

3.

[Association of Deployment and Tobacco Dependence among Soldiers].

Wesemann U, Schura R, Kowalski JT, Kropp S, Danker-Hopfe H, Rau H, Ströhle A, Thiele J, Zimmermann PL.

Gesundheitswesen. 2017 Dec;79(12):1067-1072. doi: 10.1055/s-0035-1559707. Epub 2015 Oct 22. German.

PMID:
26492392
4.

IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity.

Kocur M, Schneider R, Pulm AK, Bauer J, Kropp S, Gliem M, Ingwersen J, Goebels N, Alferink J, Prozorovski T, Aktas O, Scheu S.

Acta Neuropathol Commun. 2015 Apr 3;3:20. doi: 10.1186/s40478-015-0192-4.

5.

[When genetics spices up a severe flare of chronic inflammatory bowel disease].

Kropp S, Vijverman A, Rinken C, Lismonde JL, Deflandre J.

Rev Med Liege. 2014 Dec;69(12):654-7. French.

6.

[Levels of evidence in drug therapy for alcohol use disorders and illicit drug use].

Burucker J, Kropp S.

Fortschr Neurol Psychiatr. 2012 Dec;80(12):684-93. doi: 10.1055/s-0032-1325452. Epub 2012 Dec 10. Review. German.

PMID:
23229101
7.

A fluorescence reporter model defines "Tip-DCs" as the cellular source of interferon β in murine listeriosis.

Dresing P, Borkens S, Kocur M, Kropp S, Scheu S.

PLoS One. 2010 Dec 16;5(12):e15567. doi: 10.1371/journal.pone.0015567.

8.

The TGF-β signaling modulators TRAP1/TGFBRAP1 and VPS39/Vam6/TLP are essential for early embryonic development.

Messler S, Kropp S, Episkopou V, Felici A, Würthner J, Lemke R, Jerabek-Willemsen M, Willecke R, Scheu S, Pfeffer K, Wurthner JU.

Immunobiology. 2011 Mar;216(3):343-50. doi: 10.1016/j.imbio.2010.07.006. Epub 2010 Aug 19.

PMID:
20961651
9.

Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer.

Timofeeva M, Kropp S, Sauter W, Beckmann L, Rosenberger A, Illig T, Jäger B, Mittelstrass K, Dienemann H; LUCY-Consortium, Bartsch H, Bickeböller H, Chang-Claude J, Risch A, Wichmann HE.

Int J Cancer. 2010 Oct 1;127(7):1547-61. doi: 10.1002/ijc.25175.

10.

Musical hallucination in a patient after cochlear implantation.

Auffarth IS, Kropp S.

J Neuropsychiatry Clin Neurosci. 2009 Spring;21(2):230-1. doi: 10.1176/appi.neuropsych.21.2.230. No abstract available.

PMID:
19622701
11.

CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences.

Timofeeva MN, Kropp S, Sauter W, Beckmann L, Rosenberger A, Illig T, Jäger B, Mittelstrass K, Dienemann H; LUCY-Consortium, Bartsch H, Bickeböller H, Chang-Claude JC, Risch A, Wichmann HE.

Carcinogenesis. 2009 Jul;30(7):1161-9. doi: 10.1093/carcin/bgp102. Epub 2009 May 4.

PMID:
19414505
12.

Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer.

Chang-Claude J, Ambrosone CB, Lilla C, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Popanda O.

Br J Cancer. 2009 May 19;100(10):1680-6. doi: 10.1038/sj.bjc.6605036. Epub 2009 Apr 14.

13.

Menopausal hormone therapy and risk of clinical breast cancer subtypes.

Slanger TE, Chang-Claude JC, Obi N, Kropp S, Berger J, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Flesch-Janys D.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1188-96. doi: 10.1158/1055-9965.EPI-09-0002. Epub 2009 Mar 31.

14.

Physical activity and postmenopausal breast cancer: effect modification by breast cancer subtypes and effective periods in life.

Schmidt ME, Steindorf K, Mutschelknauss E, Slanger T, Kropp S, Obi N, Flesch-Janys D, Chang-Claude J.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3402-10. doi: 10.1158/1055-9965.EPI-08-0479. Epub 2008 Nov 24.

15.

The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J.

Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1339-43. doi: 10.1158/1055-9965.EPI-08-0162.

16.

Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy.

Flesch-Janys D, Slanger T, Mutschelknauss E, Kropp S, Obi N, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Berger J, Chang-Claude J.

Int J Cancer. 2008 Aug 15;123(4):933-41. doi: 10.1002/ijc.23655.

17.

Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer.

Sauter W, Rosenberger A, Beckmann L, Kropp S, Mittelstrass K, Timofeeva M, Wölke G, Steinwachs A, Scheiner D, Meese E, Sybrecht G, Kronenberg F, Dienemann H; LUCY-Consortium, Chang-Claude J, Illig T, Wichmann HE, Bickeböller H, Risch A.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1127-35. doi: 10.1158/1055-9965.EPI-07-2840.

18.

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.

Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson DA, Bojesen SE, Nordestgaard BG, Axelsson CK, Arias JI, Milne RL, Ribas G, González-Neira A, Benítez J, Zamora P, Brauch H, Justenhoven C, Hamann U, Ko YD, Bruening T, Haas S, Dörk T, Schürmann P, Hillemanns P, Bogdanova N, Bremer M, Karstens JH, Fagerholm R, Aaltonen K, Aittomäki K, von Smitten K, Blomqvist C, Mannermaa A, Uusitupa M, Eskelinen M, Tengström M, Kosma VM, Kataja V, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X; Australian Ovarian Cancer Management Group; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Devilee P, van Asperen CJ, Jacobi CE, Tollenaar RA, Huijts PE, Klijn JG, Chang-Claude J, Kropp S, Slanger T, Flesch-Janys D, Mutschelknauss E, Salazar R, Wang-Gohrke S, Couch F, Goode EL, Olson JE, Vachon C, Fredericksen ZS, Giles GG, Baglietto L, Severi G, Hopper JL, English DR, Southey MC, Haiman CA, Henderson BE, Kolonel LN, Le Marchand L, Stram DO, Hunter DJ, Hankinson SE, Cox DG, Tamimi R, Kraft P, Sherman ME, Chanock SJ, Lissowska J, Brinton LA, Peplonska B, Klijn JG, Hooning MJ, Meijers-Heijboer H, Collee JM, van den Ouweland A, Uitterlinden AG, Liu J, Lin LY, Yuqing L, Humphreys K, Czene K, Cox A, Balasubramanian SP, Cross SS, Reed MW, Blows F, Driver K, Dunning A, Tyrer J, Ponder BA, Sangrajrang S, Brennan P, McKay J, Odefrey F, Gabrieau V, Sigurdson A, Doody M, Struewing JP, Alexander B, Easton DF, Pharoah PD.

PLoS Genet. 2008 Apr 25;4(4):e1000054. doi: 10.1371/journal.pgen.1000054.

19.

Consortium analysis of 7 candidate SNPs for ovarian cancer.

Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, DiCioccio RA, McGuire V, Whittemore AS, Song H, Easton DF, Pharoah PDP, Garcia-Closas M, Chanock S, Lissowska J, Brinton L, Terry KL, Cramer DW, Tworoger SS, Hankinson SE, Berchuck A, Moorman PG, Schildkraut JM, Cunningham JM, Liebow M, Kjaer SK, Hogdall E, Hogdall C, Blaakaer J, Ness RB, Moysich KB, Edwards RP, Carney ME, Lurie G, Goodman MT, Wang-Gohrke S, Kropp S, Chang-Claude J, Webb PM, Chen X, Beesley J, Chenevix-Trench G, Goode EL.

Int J Cancer. 2008 Jul 15;123(2):380-388. doi: 10.1002/ijc.23448.

20.

Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk.

Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J.

Breast Cancer Res. 2008;10(2):R31. doi: 10.1186/bcr1994. Epub 2008 Apr 17.

21.

Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis.

Frank B, Wiestler M, Kropp S, Hemminki K, Spurdle AB, Sutter C, Wappenschmidt B, Chen X, Beesley J, Hopper JL; Australian Breast Cancer Family Study Investigators,, Meindl A, Kiechle M, Slanger T, Bugert P, Schmutzler RK, Bartram CR, Flesch-Janys D, Mutschelknauss E, Ashton K, Salazar R, Webb E, Hamann U, Brauch H, Justenhoven C, Ko YD, Brüning T, Silva Idos S, Johnson N, Pharoah PP, Dunning AM, Pooley KA, Chang-Claude J, Easton DF, Peto J, Houlston R; Gene Environment Interaction and Breast Cancer in Germany Group, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer Investigators, Australian Ovarian Cancer Study Management Group, Chenevix-Trench G, Fletcher O, Burwinkel B.

J Natl Cancer Inst. 2008 Mar 19;100(6):437-42. doi: 10.1093/jnci/djn037. Epub 2008 Mar 11.

PMID:
18334708
22.

The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis.

Tan XL, Nieters A, Kropp S, Hoffmeister M, Brenner H, Chang-Claude J.

Int J Cancer. 2008 Jun 1;122(11):2573-80. doi: 10.1002/ijc.23363.

23.

Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis.

Ambrosone CB, Kropp S, Yang J, Yao S, Shields PG, Chang-Claude J.

Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):15-26. doi: 10.1158/1055-9965.EPI-07-0598. Epub 2008 Jan 9.

24.

Genetic predictors of long-term toxicities after radiation therapy for breast cancer.

Kuptsova N, Chang-Claude J, Kropp S, Helmbold I, Schmezer P, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Onel K, Ambrosone CB.

Int J Cancer. 2008 Mar 15;122(6):1333-9.

25.

Good agreement between physician and self-reported hormone therapy data in a case-control study.

Kropp S, Terboven T, Hedicke J, Mutschelknauss E, Slanger T, Braendle W, Berger J, Chang-Claude J, Flesch-Janys D.

J Clin Epidemiol. 2007 Dec;60(12):1280-7. Epub 2007 Jun 28.

PMID:
17998083
26.

Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J.

Carcinogenesis. 2008 Jan;29(1):93-9. Epub 2007 Oct 31.

PMID:
17974532
27.

Test-retest reliability of self-reported reproductive and lifestyle data in the context of a German case-control study on breast cancer and postmenopausal hormone therapy.

Slanger T, Mutschelknauss E, Kropp S, Braendle W, Flesch-Janys D, Chang-Claude J.

Ann Epidemiol. 2007 Dec;17(12):993-8. Epub 2007 Sep 14.

PMID:
17855123
28.

In vitro radiation-induced expression of XPC mRNA as a possible biomarker for developing adverse reactions during radiotherapy.

Wiebalk K, Schmezer P, Kropp S, Chang-Claude J, Celebi O, Debus J, Bartsch H, Popanda O.

Int J Cancer. 2007 Nov 15;121(10):2340-5.

29.

A common coding variant in CASP8 is associated with breast cancer risk.

Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, Scollen S, Baynes C, Ponder BA, Chanock S, Lissowska J, Brinton L, Peplonska B, Southey MC, Hopper JL, McCredie MR, Giles GG, Fletcher O, Johnson N, dos Santos Silva I, Gibson L, Bojesen SE, Nordestgaard BG, Axelsson CK, Torres D, Hamann U, Justenhoven C, Brauch H, Chang-Claude J, Kropp S, Risch A, Wang-Gohrke S, Schürmann P, Bogdanova N, Dörk T, Fagerholm R, Aaltonen K, Blomqvist C, Nevanlinna H, Seal S, Renwick A, Stratton MR, Rahman N, Sangrajrang S, Hughes D, Odefrey F, Brennan P, Spurdle AB, Chenevix-Trench G; Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer, Beesley J, Mannermaa A, Hartikainen J, Kataja V, Kosma VM, Couch FJ, Olson JE, Goode EL, Broeks A, Schmidt MK, Hogervorst FB, Van't Veer LJ, Kang D, Yoo KY, Noh DY, Ahn SH, Wedrén S, Hall P, Low YL, Liu J, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Sigurdson AJ, Stredrick DL, Alexander BH, Struewing JP, Pharoah PD, Easton DF; Breast Cancer Association Consortium.

Nat Genet. 2007 Mar;39(3):352-8. Epub 2007 Feb 11. Erratum in: Nat Genet. 2007 May;39(5):688.

PMID:
17293864
30.

Predictive factors for late normal tissue complications following radiotherapy for breast cancer.

Lilla C, Ambrosone CB, Kropp S, Helmbold I, Schmezer P, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Chang-Claude J.

Breast Cancer Res Treat. 2007 Nov;106(1):143-50. Epub 2007 Jan 13.

PMID:
17221151
31.

Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation.

Ziegenbein M, Wittmann G, Kropp S.

Clin Drug Investig. 2006;26(3):117-24.

PMID:
17163242
32.

Polymorphisms in genes related to oxidative stress (CAT, MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer.

Ahn J, Ambrosone CB, Kanetsky PA, Tian C, Lehman TA, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Chang-Claude J.

Clin Cancer Res. 2006 Dec 1;12(23):7063-70.

33.
34.

[Characteristics of psychiatric patients in the accident and emergency department (ED)].

Kropp S, Andreis C, te Wildt B, Sieberer M, Ziegenbein M, Huber TJ.

Psychiatr Prax. 2007 Mar;34(2):72-5. Epub 2006 Nov 15. German.

PMID:
17106842
35.

High CSF Tau-protein concentration in delirium induced by high dose psychiatric medication.

Windhagen A, Wurster U, Kropp S, Ziegenbein M.

Aust N Z J Psychiatry. 2006 Nov-Dec;40(11-12):1039-41. No abstract available.

PMID:
17054574
36.

Constitutive mRNA expression of DNA repair-related genes as a biomarker for clinical radio-resistance: A pilot study in prostate cancer patients receiving radiotherapy.

Hümmerich J, Werle-Schneider G, Popanda O, Celebi O, Chang-Claude J, Kropp S, Mayer C, Debus J, Bartsch H, Schmezer P.

Int J Radiat Biol. 2006 Aug;82(8):593-604.

PMID:
16966187
37.

Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study.

Ambrosone CB, Tian C, Ahn J, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Chang-Claude J.

Breast Cancer Res. 2006;8(4):R40.

38.

Cytochrome P-450 2D6 and 2C19 polymorphisms and length of hospitalization in psychiatry.

Kropp S, Lichtinghagen R, Winterstein K, Schlimme J, Schneider U.

Clin Lab. 2006;52(5-6):237-40.

PMID:
16812949
39.

Alcohol related conditions represent a major psychiatric problem in emergency departments.

te Wildt BT, Andreis C, Auffahrt I, Tettenborn C, Kropp S, Ohlmeier M.

Emerg Med J. 2006 Jun;23(6):428-30.

40.

Genetic polymorphisms in the DNA double-strand break repair genes XRCC3, XRCC2, and NBS1 are not associated with acute side effects of radiotherapy in breast cancer patients.

Popanda O, Tan XL, Ambrosone CB, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude J.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1048-50. No abstract available.

41.

Extensive weight loss in a patient with schizophrenia after switching from olanzapine to aripiprazole. A case report.

Luebbe G, Kropp S, Harms E, Ziegenbein M.

Pharmacopsychiatry. 2006 Mar;39(2):76. No abstract available.

PMID:
16555168
42.

Genetic predisposition to neuroleptic malignant syndrome in siblings.

Ziegenbein M, Kropp S, Hillemacher T, Bleich S.

Ann Pharmacother. 2006 Mar;40(3):574-5. Epub 2006 Feb 14. No abstract available.

PMID:
16478811
43.

Aripiprazole-induced extrapyramidal side effects in a patient with schizoaffective disorder.

Ziegenbein M, Sieberer M, Calliess IT, Kropp S.

Aust N Z J Psychiatry. 2006 Feb;40(2):194-5. No abstract available.

PMID:
16476141
44.

Psychiatric patients turnaround times in the emergency department.

Kropp S, Andreis C, te Wildt B, Reulbach U, Ohlmeier M, Auffarth I, Ziegenbein M.

Clin Pract Epidemiol Ment Health. 2005 Dec 13;1:27.

45.

Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients.

Tan XL, Popanda O, Ambrosone CB, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude J.

Breast Cancer Res Treat. 2006 Jun;97(3):255-62. Epub 2005 Dec 6.

PMID:
16331344
46.

[Smoking as potential confounder in german epidemiological studies: standardization of assessment, quantification, and analysis].

Latza U, Hoffmann W, Terschüren C, Chang-Claude J, Kreuzer M, Schaffrath Rosario A, Kropp S, Stang A, Ahrens W, Lampert T, Straif K; German Society of Epidemiology; German Society of Social Medicine and Prevention; German Society of Medical Informatics, Biometry and Epidemiology.

Gesundheitswesen. 2005 Nov;67(11):795-802. German.

PMID:
16308812
47.

Combination of clozapine and ziprasidone in treatment-resistant schizophrenia: an open clinical study.

Ziegenbein M, Kropp S, Kuenzel HE.

Clin Neuropharmacol. 2005 Sep-Oct;28(5):220-4.

PMID:
16239761
48.

Combination of clozapine and aripiprazole: a promising approach in treatment-resistant schizophrenia.

Ziegenbein M, Sieberer M, Calliess IT, Kropp S.

Aust N Z J Psychiatry. 2005 Sep;39(9):840-1. No abstract available.

PMID:
16168043
49.

Pseudohallucinations associated with moclobemide: a case report.

Degner D, Kropp S, Porzig J, Grohmann R, Rüther E.

Pharmacopsychiatry. 2005 Jul;38(4):179-81.

PMID:
16025422
50.

Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients.

Chang-Claude J, Popanda O, Tan XL, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Ambrosone CB.

Clin Cancer Res. 2005 Jul 1;11(13):4802-9.

Supplemental Content

Support Center